Next-generation sequencing for the genetic screening of phaeochromcytomas and paragangliomas: Riding the new wave, but with caution

Clinical Endocrinology

Volumn 80, Issue 1, 2014, Pages 23-24

  Toledo, Rodrigo A ^a   Dahia, Patricia L M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DNA;

ADRENAL MEDULLA; BIOINFORMATICS; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; CLINICAL ARTICLE; CLINICAL LABORATORY; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; LABORATORY TEST; NEXT GENERATING SEQUENCING; NOTE; PARAGANGLIOMA; PARASYMPATHETIC GANGLION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

ADRENAL GLAND NEOPLASMS; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SEQUENCE ANALYSIS, DNA;

EID: 84889574339     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12357     Document Type: Note

References (15)

1. Gimenez-Roqueplo, A.P., Dahia, P.L., &, Robledo, M., (2012) An update on the genetics of paraganglioma, pheochromcytoma, and associated hereditary syndromes. Hormone and Metabolic Research, 44, 328-333.
2. Burnichon, N., Vescovo, L., Amar, L., et al,. (2011) Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Human Molecular Genetics, 20, 3974-3985.
3. Welander, J., Larsson, C., Backdahl, M., et al,. (2012) Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromcytomas. Human Molecular Genetics, 21, 5406-5416.
4. Toledo, R.A., Qin, Y., Srikantan, S., et al,. (2013) In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromcytomas and paragangliomas. Endocrine-Related Cancer, 20, 349-359.
5. Crona, J., Delgado Verdugo, A., Maharjan, R., et al,. (2013) Somatic mutations in H-RAS in sporadic pheochromcytoma and paraganglioma identified by exome sequencing. Journal of Clinical Endocrinology and Metabolism, 98, E1266-E1271.
6. Mannelli, M., Castellano, M., Schiavi, F., et al,. (2009) Clinically guided genetic screening in a large cohort of Italian patients with pheochromcytomas and/or functional or nonfunctional paragangliomas. Journal of Clinical Endocrinology and Metabolism, 94, 1541-1547.
7. Cascon, A., Lopez-Jimenez, E., Landa, I., et al,. (2009) Rationalization of genetic testing in patients with apparently sporadic pheochromcytoma/ paraganglioma. Hormone and Metabolic Research, 41, 672-675.
8. Gonzaga-Jauregui, C., Lupski, J.R., &, Gibbs, R.A., (2012) Human genome sequencing in health and disease. Annual Review of Medicine, 63, 35-61.
9. Comino-Mendez, I., Gracia-Aznarez, F.J., Schiavi, F., et al,. (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromcytoma. Nature Genetics, 43, 663-667.
10. Letouze, E., Martinelli, C., Loriot, C., et al,. (2013) SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell, 23, 739-752.
11. Yang, Y., Muzny, D.M., Reid, J.G., et al,. (2013) Clinical whole-exome sequencing for the diagnosis of mendelian disorders. New England Journal of Medicine, 369, 1502-1511.
12. Walsh, T., Lee, M.K., Casadei, S., et al,. (2010) Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proceedings of the National Academy of Sciences of the United States of America, 107, 12629-12633.
13. Rattenberry, E., Vialard, L., Yeung, A., et al,. (2013) A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromcytoma and paraganglioma. Journal of Clinical Endocrinology and Metabolism, 98, E1248-E1256.
14. McInerney-Leo, A.M., Marshall, M.S., Gardiner, B., et al,. (2013) Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas. Clinical Endocrinology, 80, 25-33.
15. Crona, J., Verdugo, A.D., Granberg, D., et al,. (2013) Next-generation sequencing in the clinical genetic screening of patients with pheochromcytoma and paraganglioma. Endocrine Connections, 2, 104-111.